Provided by Tiger Trade Technology Pte. Ltd.

Sionna Therapeutics

4.89
-0.0150-0.31%
Volume:325.18K
Turnover:1.60M
Market Cap:219.82M
PE:-2.25
High:5.12
Open:4.93
Low:4.83
Close:4.90
52wk High:54.97
52wk Low:4.01
Shares:45.00M
Float Shares:16.73M
Volume Ratio:0.36
T/O Rate:1.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1683
EPS(LYR):-1.8835
ROE:-32.34%
ROA:-21.54%
PB:0.83
PE(LYR):-2.59

Loading ...

Sionna Therapeutics price target raised to $55 from $44 at Stifel

TIPRANKS
·
May 18

LifeSci Capital Reaffirms Their Buy Rating on Sionna Therapeutics, Inc. (SION)

TIPRANKS
·
May 16

RBC Capital Sticks to Its Sell Rating for Sionna Therapeutics, Inc. (SION)

TIPRANKS
·
May 14

Analysts Are Bullish on Top Healthcare Stocks: Metagenomi, Inc. (MGX), Sionna Therapeutics, Inc. (SION)

TIPRANKS
·
May 14

Stock Track | Sionna Therapeutics Soars 5.40% Intraday Bolstered by Analyst Support and Upcoming Conference Spotlight

Stock Track
·
May 14

Wedbush Remains a Buy on Sionna Therapeutics, Inc. (SION)

TIPRANKS
·
May 13

Sionna Therapeutics joins RBC Capital Markets Global Healthcare Conference fireside chat

Reuters
·
May 13

Sionna Therapeutics Price Target Maintained With a $58.00/Share by BTIG

Dow Jones
·
May 13

Sionna Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

Sector Update: Healthcare

MT Newswires Live
·
May 12

Sionna Therapeutics reports Q1 EPS (60c), consensus (50c)

TIPRANKS
·
May 12

Earnings Flash (SION) Sionna Therapeutics Posts Q1 Net Loss $0.60 a Share, vs. FactSet Est of $0.54 Loss

MT Newswires Live
·
May 12

Sionna Therapeutics Q1 EPS $(0.60) Misses $(0.51) Estimate

Benzinga Earnings
·
May 12

Sionna Therapeutics Q1 net loss widens, misses estimates

Reuters
·
May 12

Sionna Therapeutics Inc - Maintains Cash Position of $289.9 Mln; Expects to Fund Operations Into 2028

THOMSON REUTERS
·
May 12

Sionna Therapeutics Inc Q1 Income From Operations USD -29.599 Million

THOMSON REUTERS
·
May 12

Sionna Therapeutics Inc Q1 Basic EPS USD -0.6

THOMSON REUTERS
·
May 12

Press Release: Sionna Therapeutics Reports First Quarter 2026 Financial Results

Dow Jones
·
May 12

Sionna Therapeutics director Peter A. Thompson sells 292,952 shares for $13.37 million

Reuters
·
May 12

OrbiMed Advisors disposes 292,952 Sionna Therapeutics shares for $13.5 million

Reuters
·
May 12